Corcept Therapeutics
Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators. In 2012, we received FDA approval of Korlym (mifepristone), the first approved treatment for hypercortisolism (Cushing's syndrome). Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation. The Senior Manager, Product and Pipeline Communications will support our endocrinology, oncology, and other therapeutic divisions with strategic internal and external communications.
Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs. We are a small, nimble company environment where responsibilities may shift and be redefined based on business needs.
Key skills identified from this job posting
Sign upto access all insights for this job
Website
corcept.com
Company Size
501-1000 employees
Location
Redwood City, CA
Industry
Pharmaceutical and Medicine Manufacturing
Other opportunities you might be interested in
University of Michigan
Tanium
Adventist Health Ukiah Valley
Landmark Aviation
PG&E Corporation
CME Group